Semaglutide vs Thymosin Beta-4 (Tβ4)
Updated November 4, 2026 · Reviewed by the PeptidesDB Editorial team
A data-driven comparison of Semaglutide and Thymosin Beta-4 (Tβ4) (also searched as Thymosin Beta-4 (Tβ4) vs Semaglutide) — effect profiles, evidence, side effects, and which suits weight loss, muscle, or healing goals.
Verdict
Semaglutide centers on metabolic, while Thymosin Beta-4 (Tβ4) leans toward healing. On indexed research, Semaglutide is ahead (Semaglutide: 60 studies, Human clinical; Thymosin Beta-4 (Tβ4): 6, Human clinical). Choose by goal — and read the primary studies. This is research information, not medical advice.
Key takeaways
- •Semaglutide is strongest for metabolic; Thymosin Beta-4 (Tβ4) for healing.
- •Evidence: Semaglutide Human clinical (60 studies) vs Thymosin Beta-4 (Tβ4) Human clinical (6).
- •Check the FDA-approval status chips above before assuming a legal use pathway.
Effect profiles, overlaid
At a glance
GLP-1 receptor agonist | Type 2 diabetes management
Tissue repair | Wound healing
Semaglutide vs Thymosin Beta-4 (Tβ4): side-by-side
| Metric | Semaglutide | Thymosin Beta-4 (Tβ4) |
|---|---|---|
| Class | Metabolic | Healing |
| Regulatory status | FDA-approved | Research use only |
| Evidence grade | Human clinical | Human clinical |
| Studies indexed | 60 | 6 |
| Research level | FDA Approved | Moderate Research |
| Strongest effect | Metabolic & appetite | Healing & recovery |
| Healing & recovery | 2.0 | 5.0▲ |
| Muscle & body comp | 1.0 | 2.0▲ |
| Metabolic & appetite | 5.0▲ | 1.0 |
| Neuro & mood | 2.0 | 3.0▲ |
| Sleep & circadian | 1.0▲ | 1.0▲ |
| Inflammation & immune | 2.0 | 4.0▲ |
| Skin & aesthetics | 3.0▲ | 2.0 |
▲ marks the higher AI-assigned effect score (0–5, describing where the literature concentrates — not clinical efficacy).
Mechanism & pharmacokinetics
| Property | Semaglutide | Thymosin Beta-4 (Tβ4) |
|---|---|---|
| Mechanism | GLP-1 receptor agonist | Actin-sequestering peptide; promotes cell migration & angiogenesis |
| Route | Subcutaneous injection (oral form also available) | Subcutaneous injection (research use) |
| Half-life | ~7 days (≈165 h) | — |
| Time to peak | 1–3 days | — |
| Duration of action | Weekly dosing | — |
Established pharmacology — curated for well-characterized compounds and AI-summarized otherwise. A blank (—) means no reliable single value is published (half-life figures for some peptides genuinely disagree across sources). Verify against primary sources such as FDA labels and ClinicalTrials.gov.
What is Semaglutide?
Semaglutide is a synthetic analog of glucagon-like peptide-1 (GLP-1), a hormone involved in glucose metabolism and appetite regulation. As a GLP-1 receptor agonist, semaglutide enhances insulin secretion in response to elevated blood glucose levels, suppresses glucagon secretion, and slows gastric emptying. These mechanisms contribute to improved glycemic control and increased satiety, making semaglutide a significant option in managing type 2 diabetes and obesity.
Full Semaglutide profile, mechanism & studies →What is Thymosin Beta-4 (Tβ4)?
Thymosin Beta-4 (Tβ4) is a 43-amino acid peptide that plays a significant role in tissue repair and regeneration. It is involved in various biological processes, including cell migration, angiogenesis, and inflammation modulation. Tβ4 has been shown to promote wound healing by enhancing keratinocyte migration and proliferation, as well as by facilitating the formation of new blood vessels, which are crucial for tissue repair.
Full Thymosin Beta-4 (Tβ4) profile, mechanism & studies →Which is better for your goal?
| Goal | Better fit | Why |
|---|---|---|
| Healing | Thymosin Beta-4 (Tβ4) | 5.0/5 effect signal |
| Muscle | Thymosin Beta-4 (Tβ4) | 2.0/5 effect signal |
| Metabolic | Semaglutide | 5.0/5 effect signal |
| Neuro | Thymosin Beta-4 (Tβ4) | 3.0/5 effect signal |
| Sleep | Even | Both ~1.0/5 |
| Inflammation | Thymosin Beta-4 (Tβ4) | 4.0/5 effect signal |
| Skin | Semaglutide | 3.0/5 effect signal |
Fit reflects community-perceived effect profiles — not head-to-head trials. Read each peptide's studies before deciding.
Can you stack Semaglutide and Thymosin Beta-4 (Tβ4)?
People sometimes combine peptides that target different pathways, but there is little controlled research on this specific pairing and the interactions aren't well characterized. Because at least one is a research-use compound, we don't publish stacking or dosing protocols here. Any combination should be discussed with a qualified clinician.
Semaglutide vs Thymosin Beta-4 (Tβ4): side effects
No community-reported effects logged yet.
No community-reported effects logged yet.
Anonymous community reports (count = number of reports), not clinical incidence rates.
What the research says
Semaglutide has 60 approved studies indexed (Human clinical), and Thymosin Beta-4 (Tβ4) has 6 (Human clinical). The Librarian re-checks PubMed, Europe PMC and ClinicalTrials daily, so these counts move. Open each profile to read the summaries and sources.
Frequently asked questions
Is Semaglutide or Thymosin Beta-4 (Tβ4) better?
It depends on your goal. Semaglutide is strongest for metabolic; Thymosin Beta-4 (Tβ4) for healing. Semaglutide has more indexed studies (60). See the goal-by-goal breakdown above.
Is Semaglutide or Thymosin Beta-4 (Tβ4) better for weight loss?
Semaglutide shows the stronger metabolic & appetite profile (5.0/5) in the AI-assigned effect profile — though weight-loss outcomes depend on the individual and the evidence base.
Is Semaglutide or Thymosin Beta-4 (Tβ4) better for muscle?
Thymosin Beta-4 (Tβ4) leads on the muscle & body-composition axis (2.0/5).
Which has more research, Semaglutide or Thymosin Beta-4 (Tβ4)?
Semaglutide has 60 approved studies indexed (Human clinical); Thymosin Beta-4 (Tβ4) has 6 (Human clinical). Higher counts mean more to read, not proven superiority.
Can you stack Semaglutide and Thymosin Beta-4 (Tβ4)?
Some users combine peptides, but there's little controlled data on this specific pairing, and interactions aren't well characterized. We don't publish stacking protocols for compounds that aren't FDA-approved. Discuss any combination with a qualified clinician.
What are the side effects of Semaglutide vs Thymosin Beta-4 (Tβ4)?
Semaglutide: no community-reported effects logged yet. Thymosin Beta-4 (Tβ4): none logged yet. These are anonymous reports, not incidence rates — see each profile.
Is Semaglutide or Thymosin Beta-4 (Tβ4) FDA-approved?
Semaglutide is FDA-approved. Thymosin Beta-4 (Tβ4) is not FDA-approved. Research-use status is not a legal clearance to compound or use in humans.
Is Thymosin Beta-4 (Tβ4) better than Semaglutide?
For healing, Thymosin Beta-4 (Tβ4) has the edge; for metabolic, Semaglutide does. Neither is universally "better" — it's goal-dependent, and both should be weighed against their evidence base above.
Comparing related peptides
Regulatory & legal status
Approval status varies (see the chips at the top). FDA approval and compounding rules for peptides change frequently, and research-use status is not a legal clearance for human use. The FDA does not review compounded drugs for safety, effectiveness, or quality. Verify current status with primary sources before acting. Last reviewed November 4, 2026.